about
The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sicknessRole of cytokines in Trypanosoma brucei-induced anaemia: A review of the literatureAfrican trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNAGenotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawalTrypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patientsA search for Trypanosoma brucei rhodesiense diagnostic antigens by proteomic screening and targeted cloning.Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda.Polymerase chain reaction identification of Trypanosoma brucei rhodesiense in wild tsetse flies from Nkhotakota Wildlife Reserve, MalawiIntroducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasisComparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood.Research capacity. Enabling the genomic revolution in Africa.Improved detection of Trypanosoma brucei by lysis of red blood cells, concentration and LED fluorescence microscopy.Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.Identification of coding sequences from a freshly prepared Trypanosoma brucei brucei expression library by polymerase chain reaction.Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisDetection of Group 1 Trypanosoma brucei gambiense by loop-mediated isothermal amplification.The diamidine diminazene aceturate is a substrate for the high-affinity pentamidine transporter: implications for the development of high resistance levels in trypanosomesClinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.Methods to determine the transcriptomes of trypanosomes in mixtures with mammalian cells: the effects of parasite purification and selective cDNA amplificationUse of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.Towards Point-of-Care Diagnostic and Staging Tools for Human African Trypanosomiaisis.Characterization of Calflagin, a Flagellar Calcium-Binding Protein from Trypanosoma congolenseHuman brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda.Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.Transcriptomes of newly-isolated Trypanosoma brucei rhodesiense reveal hundreds of mRNAs that are co-regulated with stumpy-form markers.New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patientsPopulation genetic structure and temporal stability among Trypanosoma brucei rhodesiense isolates in UgandaLandmarks in the evolution of technologies for identifying trypanosomes in tsetse flies.Drug resistance in human African trypanosomiasis.Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.Trypanosoma brucei brucei traverses different biological barriers differently and may modify the host plasma membrane in the process.Comparison of nucleic acid sequence-based amplification and loop-mediated isothermal amplification for diagnosis of human African trypanosomiasis.Detection of mutant P2 adenosine transporter (TbAT1) gene in Trypanosoma brucei gambiense isolates from northwest Uganda using allele-specific polymerase chain reaction.Detection of T.b. rhodesiense trypanosomes in humans and domestic animals in south east Uganda by amplification of serum resistance-associated gene.Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.Trypanosomosis agglutination card test for Trypanosoma brucei rhodesiense sleeping sickness.
P50
Q26775041-2DAE7A2C-80CE-4AE6-8755-40FF955ECEA7Q26781180-650AA5EC-FC51-4E0E-80AE-60043511F701Q28256727-131B5FE0-AEFF-48E1-8F2F-036D5A05C105Q28476222-59F7C113-C3AD-4F8F-B480-22CBCCE4DC79Q33375071-5E081A16-D8A5-4DFD-A14A-A351DBF002B1Q33474338-DDEC38C6-BC5D-4956-8593-10CEA4C9BB1FQ33540186-3D5CC30B-6756-4A62-A30D-DD6E1E8168A7Q33631307-0C7A5C38-0F85-4742-9277-BFB924B6BE90Q33721398-4277B0FA-1CA8-44D6-AA0E-E8E14CF37BFDQ33751576-BFA05491-0830-4FB0-9DA3-D027BB49D799Q33909354-C94D04AA-42E2-4021-BEF8-B6F4753E876FQ34068017-EA5F9C14-1D4D-4612-98DB-DF587B64DEE5Q34073386-D625AF62-CB98-43FF-A3A1-92E5597F5B90Q34328526-4B4CAD3A-732D-40A5-BC65-AC482A4DD68FQ34345396-3188D47E-86B1-4DC2-8B88-0B95F9CFD37DQ34613654-284A4244-BCAA-4E11-B3AC-FA5EB6C1D96BQ34927614-6AE11387-399F-4798-8A77-711DFD4D33CCQ35006575-C31AE907-6C5F-4012-BCBF-046F3E677C2AQ35067032-534F8B5A-E162-4C54-B5D6-B804E5ADEA20Q35080508-E599D90E-7599-4242-BA85-EA0176BF7755Q35126176-67886E40-0753-4A3B-86AE-EE16AB70426EQ35151759-EE65DE46-524A-403C-806A-1CF751CBE54AQ35584136-1A9BAD0E-D9DB-4A67-A560-A9E8A1F631D6Q35668603-418ABBF7-876B-4738-804E-03A25EC12856Q35876057-2992463C-0357-4469-AC16-693B06B3C53CQ35982663-3188D4F3-7C30-43FF-B3CE-E551D4EE8DE6Q36067116-5C90C9A8-AF22-4E01-AD40-E7284316A7CEQ36369970-D1932DE1-1977-44FE-A307-9FA64B5A75C2Q36417105-D90620F7-10BA-43B1-8838-A5362E664E9FQ36578354-FCAD4992-EC27-4F7C-AFD8-4F489318EDECQ36867056-A1D7F155-8A68-4311-8477-66C20365993AQ37764604-4D0FBC67-DB8B-43F6-8F40-94E4DD312392Q37940573-FFACCC1E-524D-4AA5-8E7F-F528D2464B6CQ38615202-93266B93-4DFA-4D09-BB0D-264647CB27B8Q38724642-2D1CE887-0C11-4C70-8A4C-50ED552B7174Q38863416-86D7B2E9-7339-40DB-8136-F71D95B03061Q38877140-F7B1BBF7-EC63-4F2A-A782-196ACB5DC420Q38878815-6BCB4506-F265-47EA-B6F3-AB4E7ECE1349Q38885267-75C9BEFD-460B-49A5-B318-5FEA2AE10AAAQ38886591-8113155F-16C9-4BD8-B539-A57DB2DCE47C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Enock Matovu
@ast
Enock Matovu
@en
Enock Matovu
@es
Enock Matovu
@nl
Enock Matovu
@sl
type
label
Enock Matovu
@ast
Enock Matovu
@en
Enock Matovu
@es
Enock Matovu
@nl
Enock Matovu
@sl
prefLabel
Enock Matovu
@ast
Enock Matovu
@en
Enock Matovu
@es
Enock Matovu
@nl
Enock Matovu
@sl
P106
P21
P31
P496
0000-0003-0714-7032